Persistent Renal Dysfunction in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction
Kazumasa Kurogi(Miyazaki Prefectural Hospital), Kenichi Tsujita(Kumamoto University), Soichi Komaki(Miyazaki Prefectural Hospital), Yuichiro Arima(Kumamoto University), Kenji Sakamoto(Kumamoto University), Nobuyasu Yamamoto(Miyazaki Prefectural Hospital), Eiichiro Yamamoto(Sapporo Medical University), Koichi Kaikita(Kumamoto University), Masanobu Ishii(Kumamoto Health Science University), Hiroaki Kusaka(Kumamoto University), Kyohei Marume(National Cerebral and Cardiovascular Center)
Cited by 20
Related Papers
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention
|Journal of the American College of Cardiology|2015|453
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
|New England Journal of Medicine|2024|410